Otsuka Holdings Co Ltd
TSE:4578

Watchlist Manager
Otsuka Holdings Co Ltd Logo
Otsuka Holdings Co Ltd
TSE:4578
Watchlist
Price: 8 613 JPY -2.11% Market Closed
Market Cap: 4.7T JPY
Have any thoughts about
Otsuka Holdings Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Otsuka Holdings Co Ltd stock under the Base Case scenario is 9 509.75 JPY. Compared to the current market price of 8 613 JPY, Otsuka Holdings Co Ltd is Undervalued by 9%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
9 509.75 JPY
Undervaluation 9%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Otsuka Holdings Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Otsuka Holdings Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Otsuka Holdings Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Otsuka Holdings Co Ltd

Provide an overview of the primary business activities
of Otsuka Holdings Co Ltd.

What unique competitive advantages
does Otsuka Holdings Co Ltd hold over its rivals?

What risks and challenges
does Otsuka Holdings Co Ltd face in the near future?

Summarize the latest earnings call
of Otsuka Holdings Co Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Otsuka Holdings Co Ltd.

Provide P/S
for Otsuka Holdings Co Ltd.

Provide P/E
for Otsuka Holdings Co Ltd.

Provide P/OCF
for Otsuka Holdings Co Ltd.

Provide P/FCFE
for Otsuka Holdings Co Ltd.

Provide P/B
for Otsuka Holdings Co Ltd.

Provide EV/S
for Otsuka Holdings Co Ltd.

Provide EV/GP
for Otsuka Holdings Co Ltd.

Provide EV/EBITDA
for Otsuka Holdings Co Ltd.

Provide EV/EBIT
for Otsuka Holdings Co Ltd.

Provide EV/OCF
for Otsuka Holdings Co Ltd.

Provide EV/FCFF
for Otsuka Holdings Co Ltd.

Provide EV/IC
for Otsuka Holdings Co Ltd.

Show me price targets
for Otsuka Holdings Co Ltd made by professional analysts.

What are the Revenue projections
for Otsuka Holdings Co Ltd?

How accurate were the past Revenue estimates
for Otsuka Holdings Co Ltd?

What are the Net Income projections
for Otsuka Holdings Co Ltd?

How accurate were the past Net Income estimates
for Otsuka Holdings Co Ltd?

What are the EPS projections
for Otsuka Holdings Co Ltd?

How accurate were the past EPS estimates
for Otsuka Holdings Co Ltd?

What are the EBIT projections
for Otsuka Holdings Co Ltd?

How accurate were the past EBIT estimates
for Otsuka Holdings Co Ltd?

Compare the revenue forecasts
for Otsuka Holdings Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Otsuka Holdings Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Otsuka Holdings Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Otsuka Holdings Co Ltd compared to its peers.

Compare the P/E ratios
of Otsuka Holdings Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Otsuka Holdings Co Ltd with its peers.

Analyze the financial leverage
of Otsuka Holdings Co Ltd compared to its main competitors.

Show all profitability ratios
for Otsuka Holdings Co Ltd.

Provide ROE
for Otsuka Holdings Co Ltd.

Provide ROA
for Otsuka Holdings Co Ltd.

Provide ROIC
for Otsuka Holdings Co Ltd.

Provide ROCE
for Otsuka Holdings Co Ltd.

Provide Gross Margin
for Otsuka Holdings Co Ltd.

Provide Operating Margin
for Otsuka Holdings Co Ltd.

Provide Net Margin
for Otsuka Holdings Co Ltd.

Provide FCF Margin
for Otsuka Holdings Co Ltd.

Show all solvency ratios
for Otsuka Holdings Co Ltd.

Provide D/E Ratio
for Otsuka Holdings Co Ltd.

Provide D/A Ratio
for Otsuka Holdings Co Ltd.

Provide Interest Coverage Ratio
for Otsuka Holdings Co Ltd.

Provide Altman Z-Score Ratio
for Otsuka Holdings Co Ltd.

Provide Quick Ratio
for Otsuka Holdings Co Ltd.

Provide Current Ratio
for Otsuka Holdings Co Ltd.

Provide Cash Ratio
for Otsuka Holdings Co Ltd.

What is the historical Revenue growth
over the last 5 years for Otsuka Holdings Co Ltd?

What is the historical Net Income growth
over the last 5 years for Otsuka Holdings Co Ltd?

What is the current Free Cash Flow
of Otsuka Holdings Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Otsuka Holdings Co Ltd.

Business Breakdown

Otsuka Holdings Co., Ltd. is a Japanese pharmaceutical and nutraceutical powerhouse, woven into the fabric of global health and wellness. Founded in 1964, the company has consistently focused on the discovery, development, and commercialization of innovative products aimed at tackling unaddressed medical needs. Otsuka's broad portfolio includes prescription drugs, particularly in the areas of psychiatry, neurology, and oncology, complemented by a robust range of consumer healthcare products such as drinks and nutritional supplements. With a commitment to research and development, the company invests significantly in innovative drug solutions, resulting in a legacy marked by breakthroughs suc...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Otsuka Holdings Co Ltd

Current Assets 1.4T
Cash & Short-Term Investments 606.3B
Receivables 475.5B
Other Current Assets 353.1B
Non-Current Assets 2.2T
Long-Term Investments 503.5B
PP&E 578.8B
Intangibles 901B
Other Non-Current Assets 179.6B
Current Liabilities 747B
Accounts Payable 182.8B
Other Current Liabilities 564.3B
Non-Current Liabilities 342.6B
Long-Term Debt 147.8B
Other Non-Current Liabilities 194.8B
Efficiency

Earnings Waterfall
Otsuka Holdings Co Ltd

Revenue
2.3T JPY
Cost of Revenue
-648.6B JPY
Gross Profit
1.6T JPY
Operating Expenses
-1.2T JPY
Operating Income
400.1B JPY
Other Expenses
-248.5B JPY
Net Income
151.6B JPY

Free Cash Flow Analysis
Otsuka Holdings Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In the second quarter of FY 2024, the company saw significant growth with revenue increasing 17% to JPY 1,109.8 billion and business profit up 37.8% to JPY 213.6 billion. Strong performance in pharmaceutical and nutraceutical businesses fueled this growth. The revenue forecast for FY 2024 has been revised upward by JPY 175 billion to JPY 2,315 billion, and business profit is now projected to be JPY 390 billion. Notably, net profit is expected to double compared to 2023, reaching JPY 240 billion. The company also announced a JPY 50 billion share repurchase plan for FY 2024.

What is Earnings Call?
Fundamental Scores

Profitability Score
Profitability Due Diligence

Otsuka Holdings Co Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Free Cash Flow
ROIC is Increasing
55/100
Profitability
Score

Otsuka Holdings Co Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Otsuka Holdings Co Ltd's solvency score is 89/100. The higher the solvency score, the more solvent the company is.

89/100
Solvency
Score

Otsuka Holdings Co Ltd's solvency score is 89/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Otsuka Holdings Co Ltd

Wall Street analysts forecast Otsuka Holdings Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Otsuka Holdings Co Ltd is 9 008.45 JPY with a low forecast of 6 161 JPY and a high forecast of 11 340 JPY.

Lowest
Price Target
6 161 JPY
28% Downside
Average
Price Target
9 008.45 JPY
5% Upside
Highest
Price Target
11 340 JPY
32% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Otsuka Holdings Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Otsuka Holdings Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Otsuka Holdings Co Ltd Logo
Otsuka Holdings Co Ltd

Country

Japan

Industry

Pharmaceuticals

Market Cap

4.7T JPY

Dividend Yield

1.39%

Description

Otsuka Holdings Co., Ltd. engages in the manufacture and sale of pharmaceuticals and nutritional supplements. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 33,226 full-time employees. The company went IPO on 2010-12-15. The firm operates through four business segments. The Medical-related segment is engaged in the sale of ethical drugs, and the research development and export of therapeutic drugs. The Nutraceuticals-related segment is engaged in the manufacture, purchase and sale of nutraceuticals-related products, such as functional food and dietary supplements. The Consumer-related segment is engaged in the manufacture and sale of consumer products and mineral water. The Others segment is engaged in the manufacture and sale of chemical products, the manufacture, sale and import of measuring equipment, and the manufacture of synthetic resin molding products.

Contact

TOKYO-TO
Chiyoda-ku
2-9, Kandatsukasa-machi
+81367171410.0
www.otsuka.com

IPO

2010-12-15

Employees

33 226

Officers

CEO, President & Representative Director
Mr. Tatsuo Higuchi
COO & Representative Director
Mr. Makoto Inoue
Executive Deputy President & Executive Director
Mr. Yoshiro Matsuo
CFO & Executive Director
Ms. Yuko Makino
Vice President of Investor Relations, Public Relations & Sustainability Promotion
Tomohiro Emura Ph.D.
Senior VP & Director of Human Resource Planning Department
Akiko Ryu
Show More
Executive Director
Mr. Shuichi Takagi
Senior Vice President of Nutraceutical Business, Global Strategy & Planning Headquarters
Chiaki Sakurai
Show Less

See Also

Discover More
What is the Intrinsic Value of one Otsuka Holdings Co Ltd stock?

The intrinsic value of one Otsuka Holdings Co Ltd stock under the Base Case scenario is 9 509.75 JPY.

Is Otsuka Holdings Co Ltd stock undervalued or overvalued?

Compared to the current market price of 8 613 JPY, Otsuka Holdings Co Ltd is Undervalued by 9%.

Back to Top